Robert Mashal - 11 Aug 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Director
Signature
/s/ Stephen Dang, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
11 Aug 2025
Net transactions value
$0
Form type
4
Filing time
13 Aug 2025, 16:30:14 UTC
Previous filing
23 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mashal Robert Director C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK /s/ Stephen Dang, Attorney-in-Fact 13 Aug 2025 0002007102

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Gift $0 -350,001 -47% $0.000000 391,178 11 Aug 2025 Class A Common Stock 350,001 $1.55 Direct F1, F2
transaction NUVB Stock Option (Right to buy) Gift $0 +350,001 $0.000000 350,001 11 Aug 2025 Class A Common Stock 350,001 $1.55 By Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option are fully vested.
F2 The reported transaction involves the reporting person's transfer of option to his irrevocable trust.